Sort
30,917 grants matching “tumor microenvironment”
UNTAPPED THERAPEUTIC TARGETS IN THE TUMOR MICROENVIRONMENT
$787,500Cedars-Sinai Medical Center · · FY2016 · Department of Defense
Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines
$787,127James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Clinical trials employing cancer vaccine combination therapies
$787,127James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas
$787,123Anirban Maitra · University Of Tx Md Anderson Can Ctr · U01 · FY2016 · CA
Imaging and Molecular Correlates of Progression in Cystic Neoplasms of the Pancreas
$787,123Anirban Maitra · University Of Tx Md Anderson Can Ctr · U01 · FY2017 · CA
Defining the Roles of Bone Marrow Adipocytes and FABP4/5 Signaling in Multiple Myeloma Drug Resistance
$786,900Michaela R. Reagan · Mainehealth · R37 · FY2025 · CA
Functional Analysis of TEM5 and TEM8
$786,773Bradley D St Croix · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
Single-cell DNA methylation analysis of human cancer
$786,638Kenneth Aldape · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Image-based models of tumor-immune dynamics in glioblastoma
$785,579Kristin R Swanson · Mayo Clinic Arizona · U01 · FY2021 · CA
Molecular Analysis of Breast Cancer Metastasis to the Brain
$785,037Patricia Schriver Steeg · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Regulation of immunity by the cGAS-STING pathway
$784,885Jonathan C Kagan · Boston Children'S Hospital · R01 · FY2022 · AI
Tumor microenvironments determing migration, dissemination and dormancy
$784,552John S Condeelis · Albert Einstein College Of Medicine · U54 · FY2012 · CA
Impact of Cellular and Extracellular Host Components on Tumor Progression
$784,417Richard O Hynes · Massachusetts Institute Of Technology · U54 · FY2011 · CA
MODULATION OF TUMOR MICROENVIRONMENT TO HINDER CANCER PROGRESSION AND THERAPEUTIC RESISTANCE
$784,385Duke University · · FY2022 · Department of the Army
Development of TGF-beta antagonists for cancer therapy
$784,065Lalage Wakefield · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Preclinical development of breakthrough immunotherapy for brain tumors
$783,609Hideho Okada · University Of California, San Francisco · R35 · FY2025 · NS
Interdisciplinary Small Animal Imaging for Oncology
$783,537Johns Hopkins University · R24 · FY2003 · CA
YALE CANCER CENTER CALABRESI IMMUNO-ONCOLOGY TRAINING PROGRAM
$783,348Harriet M Kluger · Yale University · K12 · FY2024 · CA
YALE CANCER CENTER CALABRESI IMMUNO-ONCOLOGY TRAINING PROGRAM
$783,348Harriet M Kluger · Yale University · K12 · FY2025 · CA
Synthetic circuit technologies for precision control and signal processing in mammalian cells
$783,175Ahmad Samir Khalil · Boston University (Charles River Campus) · R01 · FY2024 · EB
Dynamics in the Tissue State: From Normal to Tumor and Back
$782,877Jan T. Liphardt · University Of California Berkeley · U54 · FY2012 · CA
PROJECT 1: TIME-Based Spatiotemporal Cancer Immunograms Predictive for Immunotherapy-Targeted Therapy Sequential Combinations
$782,862James R. Heath · Institute For Systems Biology · U54 · FY2025 · CA
AGR2-superantigen vaccine conjugate for the treatment of pancreaticductal adenocarcinoma
$782,691Reeder McNeil Robinson · Leukogene Therapeutics, Inc. · R44 · FY2023 · CA
Elucidating the molecular and contextual basis for IDLE ultralow risk lesions and the tumor immune microenvironment of high risk in situ and invasive breast cancers
$782,497Laura J Esserman · University Of California, San Francisco · U01 · FY2017 · CA
Immunophysiological Mechanisms in the Biological Therapy of Cancer
$782,272Robert Wiltrout · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA